Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

examining differences in the rates of breast reconstruction following mastectomies.

2.

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

3.

FET-PET Agent Approved for Glioma Imaging

4.

A large study found that monolayers were superior in detecting cancer.

5.

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot